A new drug appears to halt Alzheimer's disease in its tracks, at least for some patients. Is it a "breakthrough?" Judith Graham says no on the Association of Health Care Journalists' site, and calls out journalists who suggest otherwise: "Especially on a topic like Alzheimer’s, so fraught with emotion and hopelessness, the responsibility for getting it right – not too dewy-eyed, not too jaundiced, carefully balanced and hewing closely to the facts – is a heavy one."
